Home/ImPact Biotech/Dr. Morag al

DM

Dr. Morag al

Chief Medical Officer

Therapeutic Areas

Oncology Immunotherapy

ImPact Biotech Pipeline

Drug	Indication	Phase
Padeliporfin VTP	Upper Tract Urothelial Carcinoma (UTUC)	Phase 1/III

Leadership Team at ImPact Biotech

Global Head of Technical Operations

View full ImPact Biotech profile